T. A. Larson

Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital

Dale N. Gerding, T. A. Larson, Rita Hughes et al. · Antimicrobial Agents and Chemotherapy · 1991 · 249 citations · Full text

Life Sciences, Microbiology, Pharmacotherapy +17

Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic model

Mark W. Garrison, Kyle Vance‐Bryan, T. A. Larson et al. · Antimicrobial Agents and Chemotherapy · 1990 · 104 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Aminoglycoside resistance in gram-negative bacilli during increased amikacin use

Dale N. Gerding, T. A. Larson · The American Journal of Medicine · 1985 · 100 citations

Life Sciences, Microbiology, Pharmacology +16

Pharmacokinetics of fluconazole in immune-compromised children with leukemia or other hematologic diseases.

Russell E. Seay, T. A. Larson, John P. Toscano et al. · PubMed · 1995 · 48 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacokinetics of Fluconazole in Immune‐Compromised Children With Leukemia or Other Hematologic Disease

Russell E. Seay, T. A. Larson, John P. Toscano et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 1995 · 43 citations

Pharmacy, Pharmacokinetics, Pharmacology +16